
Cardiovascular Systems (NASDAQ: CSII)
Some price data may be temporarily unavailable.
Cardiovascular Systems Return vs. S&P
1 Year | 5 Year | 5 Year Annualized | Since IPO |
---|
Cardiovascular Systems Company Info
Cardiovascular Systems, Inc. (CSI) is devoted to developing and commercializing innovative solutions for treating peripheral and coronary vascular disease. Their primary focus is helping physicians conquer even the most difficult disease states, including calcium, given the complications. Cardiovascular Systems develop solutions for the treatment of peripheral and coronary artery disease, to help physicians conquer calcium, one of the largest challenges when treating PAD and CAD.
News & Analysis
Why Cardiovascular Systems Stock Is Soaring Today
The medtech company has agreed to a buyout offer from Abbott Laboratories.
Why Cardiovascular Systems Is Down Today
The market is reacting to the company's decision to initiate a public offering of common stock.
Why Cardiovascular Systems Inc's Stock Flatlined Today
A revenue miss at the medical-device maker.
Cardiovascular Systems Inc is Crashing Today: Here's Why
Cardiovascular Systems falls hard after reporting preliminary quarterly results. Here's what investors need to know.
Why Cardiovascular Systems Inc is Crashing Today
Cardiovascular Systems stock fell hard today after the company reported revenue results below its guidance range.
Why Cardiovascular Systems, Inc. Shares Are Feeling Pumped
Cardiovascular Systems rockets higher after reporting its second-quarter earnings results. Should shareholders be excited or concerned following this report?
Abiomed, Inc.: The Best Medical Device Companies of 2013
Abiomed's Impella heart pumps are carving out an important niche in cardiac cath labs.
Why Cardiovascular Systems Inc. Shares Were Pumped Up
The Food and Drug Administration gives a thumbs-up to Cardiovascular Systems' revolutionary calcified artery-fighting device.
Valuation
Earnings Transcripts
Cardiovascular Systems (CSII) Q4 2022 Earnings Call Transcript
CSII earnings call for the period ending June 30, 2022.
Cardiovascular Systems (CSII) Q3 2022 Earnings Call Transcript
CSII earnings call for the period ending March 31, 2022.
Cardiovascular Systems (CSII) Q2 2022 Earnings Call Transcript
CSII earnings call for the period ending December 31, 2021.
Cardiovascular Systems, inc (CSII) Q1 2022 Earnings Call Transcript
CSII earnings call for the period ending September 30, 2021.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.